₦ NGN
Language
Currency
‹ All headlines
ScienceDaily Health

Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

3 weeks ago
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go
Download APK
feedback Feedback